skip to main content

S. 1683: Preventing Foreign Attempts To Erode Healthcare Innovation Act

Call or Write Congress

About the bill

In the name of ending the pandemic, is the administration’s proposal a step too far?


In 2020, companies including Pfizer, Moderna, and Johnson & Johnson developed effective COVID-19 vaccines in record time. In no small part, that was because of the intellectual property (IP) protections they were granted for their creations.

The average cost of developing a new drug is close to $3 billion. Under U.S. patent law, a patented product can be sold exclusively by the creator or manufacturer for 20 years. The idea is that this allows entrepreneurs and companies to earn back the often enormous costs for research and development, thus incentivizing innovations.

After that, generic drugs and medicines can be sold beginning two decades after the introduction of a brand-name medicine, on …

Sponsor and status

Tim Scott

Sponsor. Junior Senator for South Carolina. Republican.

Read Text »
Last Updated: May 18, 2021
Length: 4 pages
May 18, 2021
117th Congress (2021–2023)

Introduced on May 18, 2021

This bill is in the first stage of the legislative process. It was introduced into Congress on May 18, 2021. It will typically be considered by committee next before it is possibly sent on to the House or Senate as a whole.

Other activity may have occurred on another bill with identical or similar provisions.


3 Cosponsors (3 Republicans)

3% chance of being enacted according to Skopos Labs (details)


May 18, 2021

Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.

If this bill has further action, the following steps may occur next:
Passed Committee

Passed Senate

Passed House

Signed by the President

S. 1683 is a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

Bills numbers restart every two years. That means there are other bills with the number S. 1683. This is the one from the 117th Congress.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“S. 1683 — 117th Congress: Preventing Foreign Attempts To Erode Healthcare Innovation Act.” 2021. December 6, 2022 <>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from, the official portal of the United States Congress. is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.